https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-and-Forest-Announce-Linaclotide-New-Drug-Application-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation-and-Chronic-Constipation-Accepted-for-FDA-Review/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- October 24, 2011